the Fetal Epicardial Thickness in Obese Pregnant Women (EFT)

Sponsor
Necmettin Erbakan University (Other)
Overall Status
Completed
CT.gov ID
NCT05948319
Collaborator
(none)
120
1
2
6.9
17.3

Study Details

Study Description

Brief Summary

the effects of fetal EFT on fetal cardiac function and fetal and maternal outcomes were investigated in obese pregnant women compared with normal-weight pregnant women.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Doppler ultrasonography
N/A

Detailed Description

All pregnant women underwent a comprehensive fetal anomaly screening. One obstetrician (S.D.) assessed all of the measurements. Every measurement was performed using a convex 2-5 MHz Voluson E8 probe (GE Healthcare, Milwaukee, WI). Fetal biometry, UA, MCA Doppler, cerebroplacental ratio (CPR), modified MPI (mod-MPI), and EFT were assessed in accordance with the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) guidelines

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
case controlcase control
Masking:
Single (Participant)
Masking Description:
obese and non obese pregnant women
Primary Purpose:
Screening
Official Title:
The Effect of Myocardial Performance Index and Fetal Epicardial Thickness on Perinatal Outcomes in Obese Pregnant Women
Actual Study Start Date :
Oct 1, 2022
Actual Primary Completion Date :
Apr 30, 2023
Actual Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: myocardial performance and epicard thickness in obese pregnant women

obese pregnant versus normal-weight pregnant women were evaluated for MPI and fetal epicardial thickness

Diagnostic Test: Doppler ultrasonography
Doppler study was performed in all cases. perinatal outcomes were evaluated.

Active Comparator: obese pregnant

obese pregnant versus normal-weight pregnant women were evaluated for MPI and fetal epicardial thickness

Diagnostic Test: Doppler ultrasonography
Doppler study was performed in all cases. perinatal outcomes were evaluated.

Outcome Measures

Primary Outcome Measures

  1. birth weight (gram) [birth 1 week]

    fetal outcome

  2. stillbirth rate (%) [birth 1 week]

    fetal outcome

  3. NICU admission [6 months]

    fetal outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Obese pregnant women

  • normal-weight pregnant women

  • 24-40 gestational week

Exclusion Criteria:

Twin pregnancies, structural and chromosomal abnormalities, fetal rhesus isoimmunization, fetal growth restriction, cases with infections detected by maternal serological tests, pregestational or gestational diabetes (All patients underwent a 75-gram glucose load test at 24 weeks to rule out diabetes), preeclampsia, premature rupture of membranes were excluded from the study -

Contacts and Locations

Locations

Site City State Country Postal Code
1 Necmettin Erbakan University Konya Turkey 42140

Sponsors and Collaborators

  • Necmettin Erbakan University

Investigators

  • Study Director: şükran DR doğru, md, NECMETTİN ERBAKAN UNIVERCITY
  • Principal Investigator: fatih dr akkuş, md, NECMETTİN ERBAKAN UNIVERCITY

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
şükran doğru, medical director, Necmettin Erbakan University
ClinicalTrials.gov Identifier:
NCT05948319
Other Study ID Numbers:
  • 14221/neu
First Posted:
Jul 17, 2023
Last Update Posted:
Jul 17, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by şükran doğru, medical director, Necmettin Erbakan University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 17, 2023